Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tempus AI, Inc. - Class A Common Stock
(NQ:
TEM
)
87.78
-3.24 (-3.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tempus AI, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Whitehawk Therapeutics Dips Over 8% In After-Hours Trading Despite New Tempus AI Partnership
Today 0:44 EDT
Whitehawk Therapeutics announced a multi-year partnership with Tempus AI, but its stock fell 8.81% in after-hours trading following the news.
Via
Benzinga
Topics
Artificial Intelligence
Whitehawk Therapeutics Stock Rallies 25% On Tempus AI Collaboration Deal: Retail Hopes For A Rally Toward $5 Mark
October 16, 2025
Via
Stocktwits
Topics
Artificial Intelligence
Whitehawk Therapeutics Stock Is Trading Higher Thursday: What's Going On?
October 16, 2025
Whitehawk Therapeutics shares are rising Thursday after the company announced a multi-year collaboration with Tempus AI to support the development of its oncology pipeline.
Via
Benzinga
Topics
Artificial Intelligence
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
October 16, 2025
From
Tempus AI, Inc.
Via
Business Wire
Tempus AI Hits $100—Are Shares Due for a Pullback?
October 15, 2025
After hitting $100, Tempus AI has retreated, but shares have still provided huge returns. Multiple factors suggest that the stock could see a larger correction.
Via
MarketBeat
Topics
Artificial Intelligence
Government
Initial Public Offering
Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
October 15, 2025
From
Tempus AI, Inc.
Via
Business Wire
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns
October 15, 2025
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.
Via
Benzinga
Topics
Artificial Intelligence
Nancy Pelosi, Cathie Wood Align On These 4 Stocks – Do You Own Any?
October 10, 2025
Shared stocks between Nancy Pelosi and Cathie Wood include Alphabet, Amazon, NVIDIA, and Tempus AI. They also both own stakes in private company Databricks.
Via
Benzinga
Topics
Artificial Intelligence
Tempus AI Up Nearly 185% Since Nancy Pelosi's Reported Purchase In January 2025
October 10, 2025
Track Nancy Pelosi's 2025 stock trades. Disclosures reveal a Tempus AI (TEM) options buy nets huge gains along with a Broadcom move.
Via
Benzinga
Topics
Artificial Intelligence
Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy
October 09, 2025
From
Tempus AI, Inc.
Via
Business Wire
Tempus AI's $100 Breakout — Billionaire Cliff Asness Reaps 60% Windfall
October 09, 2025
Tempus AI (TEM) stock has soared past $100, giving a 60% boost to billionaire Cliff Asness' TEM position in the AI-diagnostic stock.
Via
Benzinga
Topics
Artificial Intelligence
Tempus AI Executive Ryan Fukushima Sells $460,000 Worth Of Stock
October 08, 2025
Tempus AI stock nudged higher after hours following insider sales by COO Ryan Fukushima's spouse under a pre-arranged trading plan.
Via
Benzinga
Topics
Artificial Intelligence
These 5 Beaten-Down Tech Stocks Could Catch Fire Next
October 08, 2025
Highly shorted stocks with positive growth outlooks and improving market support are set up for short squeezes: this is a look at five.
Via
MarketBeat
Topics
Artificial Intelligence
Nancy Pelosi's Tempus Play Might Be Smartest Trade In Washington — Stock Surges 200%
October 08, 2025
An AI stock disclosed as a new 2025 purchase by Nancy Pelosi is up over 200% since she took the position in January.
Via
Benzinga
Topics
Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
October 08, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 06, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 03, 2025
Via
Benzinga
Why Tempus AI Stock Was Motoring Higher This Week
October 03, 2025
A recent acquisition seems to be paying off already for the tech-forward healthcare data specialist.
Via
The Motley Fool
Topics
Artificial Intelligence
AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants
October 01, 2025
As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This...
Via
MarketMinute
Topics
Artificial Intelligence
Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On?
October 01, 2025
Shares of Tempus AI Inc (NASDAQ: TEM) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here's what investors need to know.
Via
Benzinga
Topics
Artificial Intelligence
Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
October 01, 2025
From
Ambry Genetics
Via
Business Wire
Affirm Holdings, Oklo, Tempus AI Are Among Top 10 Large Cap Losers Last Week (Sep. 22- Sep. 26): Are The Others In Your Portfolio?
September 28, 2025
These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?
Via
Benzinga
Topics
Artificial Intelligence
3 Healthcare Stocks Using AI to Drive Growth
September 27, 2025
AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation
Via
MarketBeat
Topics
Artificial Intelligence
What Are 2 Great Tech Stocks to Buy Right Now?
September 27, 2025
These two tech stocks could deliver big returns for investors willing to hold for the long term.
Via
The Motley Fool
Topics
Artificial Intelligence
Stocks
7 Analysts Have This To Say About Tempus AI
September 26, 2025
Tempus AI (NASDAQ: TEM) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings,...
Via
Benzinga
Topics
Artificial Intelligence
Why Tempus AI Stock Is Plunging This Week
September 25, 2025
When a well-known growth investor decides to trim her position in a stock, investors sit up and take note.
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Cathie Wood Makes Trading Blitz: Buys Alibaba Stock Woth $11 Million, Dumps AMD And This AI Stock
September 24, 2025
On Wednesday Sept. 24, 2025, Cathie Wood-led Ark Invest purchased nearly $11 million worth of Alibaba stock while selling shares of AMD and Tempus AI.
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead
September 23, 2025
Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.
Via
Benzinga
Topics
Artificial Intelligence
IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance
September 22, 2025
The company is focusing on RNA sequencing as a means of assisting with drug development.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Intellectual Property
Tempus AI (TEM) Stock Is Rising Monday: What's Going On?
September 22, 2025
Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD device.
Via
Benzinga
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.